Education
About Us
Working with TipRanks
Follow Us
Casdin Capital, LLC Insider Profile
4 Followers
Casdin Capital, LLC, Ten Percent Owner at Constellation Pharmaceuticals, holds 3.38M shares in GeneDx Holdings (Ticker: WGS), holds 2.02M shares in 2seventy bio (Ticker: TSVT), holds 1.61M shares in Generation Bio (Ticker: GBIO). Most recently, Casdin Capital, LLC Sold ― shares of GeneDx Holdings on Aug 22, 2025 for an estimated value of $60.45M.
Casdin Capital, LLC Constellation Pharmaceuticals (CNST)Ten Percent Owner
Constellation Pharmaceuticals (CNST)
Ten Percent Owner
Ranked #130 out of 103,104 Corporate Insiders
Profitable Transactions
8 out of 10 Profitable Transactions
Average Return
+168.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Casdin Capital, LLC holds in companies
Most Profitable Insider Trade
The most profitable trade made by Casdin Capital, LLC
Casdin Capital, LLC's Trading History
Constellation Pharmaceuticals
Jul 23, 2018
―
Uninformative Buy
―
$5.40M
Fulcrum Therapeutics
Jul 22, 2019
Ten Percent Owner
Uninformative Buy
―
$4.16M
Generation Bio
Jun 18, 2020
Ten Percent Owner
Uninformative Buy
―
$10.39M
GeneDx Holdings
Aug 22, 2025
Director, Ten Percent Owner
Informative Sell
60.45M
$434.90M
2seventy bio
Jun 12, 2024
―
Uninformative Buy
―
$10.11M
List of latest transactions for each holding click on a transaction to see Casdin Capital, LLC's performance on stock
You May Also Like
Casdin Capital, LLC insider profile FAQ
What is the percentage of profitable transactions made by Casdin Capital, LLC?
The percentage of profitable transactions made by Casdin Capital, LLC is 80%.
What is the average return per transaction made by Casdin Capital, LLC?
The average return per transaction made by Casdin Capital, LLC is 168.50%.
What stocks does Casdin Capital, LLC hold?
Casdin Capital, LLC holds: CNST, FULC, GBIO, WGS, TSVT stocks.
What was Casdin Capital, LLC’s latest transaction?
Casdin Capital, LLC latest transaction was an Informative Sell of $60.45M.
What was Casdin Capital, LLC's most profitable transaction?
Casdin Capital, LLC’s most profitable transaction was an Informative Buy of WGS stock on March 6, 2024. The return on the trade was 800.00%.
What is Casdin Capital, LLC's role in Constellation Pharmaceuticals?
Casdin Capital, LLC's role in Constellation Pharmaceuticals is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.